LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
- Resource Type
- Article
- Authors
- Conboy, Caitlin B.; Yonkus, Jennifer A.; Buckarma, EeeLN H.; Mun, Dong-Gi; Werneburg, Nathan W.; Watkins, Ryan D.; Alva-Ruiz, Roberto; Tomlinson, Jennifer L.; Guo, Yi; Wang, Juan; O’Brien, Daniel; McCabe, Chantal E.; Jessen, Erik; Graham, Rondell P.; Buijsman, Rogier C.; Vu, Diep; de Man, Jos; Ilyas, Sumera I.; Truty, Mark J.; Borad, Mitesh; Pandey, Akhilesh; Gores, Gregory J.; Smoot, Rory L.
- Source
- In Journal of Hepatology September 2022
- Subject
- Hepatic and Biliary Cancer
- Language
- ISSN
- 0168-8278